These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31516222)

  • 1. Salivary calcium as a diagnostic tool for screening of osteoporosis in postmenopausal women.
    Kumbhojkar SV; Kale AD; Kumbhojkar VR; Desai KM
    J Oral Maxillofac Pathol; 2019; 23(2):192-197. PubMed ID: 31516222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of salivary calcium level as a screening tool for the osteoporosis in the post-menopausal women: A prospective study.
    Wasti A; Wasti J; Singh R
    Indian J Dent Res; 2020; 31(2):252-256. PubMed ID: 32436906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary Content Might be Associated With Skeletal Status in Postmenopausal Women: SilesiaOsteoActive Study Results.
    Tabor E; Hűpsch H; Rokicka J; Sierpińska T; Konstantynowicz J; Orywal K; Pluskiewicz W
    J Clin Densitom; 2021; 24(1):14-21. PubMed ID: 32146075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary calcium concentration as a screening tool for postmenopausal osteoporosis.
    Rabiei M; Masooleh IS; Leyli EK; Nikoukar LR
    Int J Rheum Dis; 2013 Apr; 16(2):198-202. PubMed ID: 23773645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
    Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population.
    Han W; Bai X; Wang N; Han L; Sun X; Chen X
    Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of predictors of bone mineral density and hip geometry in postmenopausal women: a cross-sectional study.
    Singh R; Gupta S; Awasthi A
    Arch Osteoporos; 2015; 10():39. PubMed ID: 26556785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
    Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
    J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy.
    Prince RL; Smith M; Dick IM; Price RI; Webb PG; Henderson NK; Harris MM
    N Engl J Med; 1991 Oct; 325(17):1189-95. PubMed ID: 1922205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.
    Meunier PJ; Vignot E; Garnero P; Confavreux E; Paris E; Liu-Leage S; Sarkar S; Liu T; Wong M; Draper MW
    Osteoporos Int; 1999; 10(4):330-6. PubMed ID: 10692984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report.
    Diamond T; Ng AT; Levy S; Magarey C; Smart R
    Osteoporos Int; 1996; 6(4):329-33. PubMed ID: 8883124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of salivary calcium and salivary parathyroid levels in postmenopausal women with and without oral dryness.
    Singh B; Sheikh S; Pallagatti S; Kaur K; Sohi R
    Contemp Clin Dent; 2013 Oct; 4(4):488-92. PubMed ID: 24403794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower vitamin E serum levels are associated with osteoporosis in early postmenopausal women: a cross-sectional study.
    Mata-Granados JM; Cuenca-Acebedo R; Luque de Castro MD; Quesada Gómez JM
    J Bone Miner Metab; 2013 Jul; 31(4):455-60. PubMed ID: 23536191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TBS in early postmenopausal women with severe vertebral osteoporosis.
    Pouillès JM; Gosset A; Breteau A; Trémollieres FA
    Bone; 2021 Jan; 142():115698. PubMed ID: 33091641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen.
    Ongphiphadhanakul B; Piaseu N; Tung SS; Chailurkit L; Rajatanavin R
    Maturitas; 2000 Feb; 34(2):179-84. PubMed ID: 10714913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study.
    Bansal N; Katz R; de Boer IH; Kestenbaum B; Siscovick DS; Hoofnagle AN; Tracy R; Laughlin GA; Criqui MH; Budoff MJ; Li D; Ix JH
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4890-8. PubMed ID: 24092825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of estrogen replacement therapy upon bone mineral density in thyroxine-treated postmenopausal women with a past history of thyrotoxicosis.
    Franklyn JA; Betteridge J; Holder R; Sheppard MC
    Thyroid; 1995 Oct; 5(5):359-63. PubMed ID: 8563472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.